Innovations in colorectal cancer treatment: trifluridine and tipiracil with bevacizumab for improved outcomes - a reviewdoi:10.3389/fonc.2024.1296765COLORECTAL cancerTHERAPEUTICSUNITED States. Food & Drug AdministrationMETASTASISCLINICAL trialsCANCER treatment...
The outcomes of treatment of colorectal cancer (surgery, radiation therapy, and chemotherapy) may have profound effects on quality of life (QOL). Furthermore, colorectal cancer screening and treatment may be expensive, and the costs are important from a policy perspective. This review examines ...
Targeted therapies can work on cancerous cells by directly inhibiting cell proliferation, differentiation, and migration. The tumor microenvironment, including local blood vessels and immune cells, might also be altered by targeted drugs to impede tumor growth and enact stronger immune surveillance and a...
Tissue gene mutation profiles in patients with colorectal cancer and their clinical implications Biomed. Rep., 13 (1) (2020), pp. 43-48 CrossrefView in ScopusGoogle Scholar [7] L.H. Biller, D. Schrag Diagnosis and treatment of metastatic colorectal cancer: a review JAMA, 325 (7) (2021...
With this transformation has come increased interest in the unique problems, risks, needs, and concerns of survivors who have completed treatment and are cancer-free. They often suffer late/long-term side effects of therapies that may compromise their QoL such as fatigue, sleep difficulty, fear ...
ADJUVANT TREATMENT OF COLORECTAL CANCER. Provides information on a study which described the adjuvant therapy for colorectal cancer. Early adjuvant trials in colon cancer; Unresolved issues in rec... Saltz,MD,Leonard,... - 《Annual Review of Medicine》 被引量: 563发表: 1997年 Adjuvant therapy ...
Xu X, et al. Efficacy and safety of regorafenib and fruquintinib as third-line treatment for colorectal cancer: a narrative review. Transl Cancer Res 2022;11(1):276-287. doi: 10.21037/tcr-20-3539 Sun Q, et al. (2014) Discovery of fruquintinib, ...
et al. Fluorouracil, leucovorin, and irinotecan plus cetuximab treatment and RAS mutations in colorectal cancer. J. Clin. Oncol. 33, 692–700 (2015). PubMed Google Scholar Hammond, W. A., Swaika, A. & Mody, K. Pharmacologic resistance in colorectal cancer: a review. Ther. Adv. Med....
Genetics, diagnosis and management of colorectal cancer (Review) Colorectal cancer (CRC) is the third most common type of cancer worldwide and a leading cause of cancer death. Surgery represents the mainstay of treatment... M De Rosa,U Pace,D Rega,... - 《Oncology Reports》 被引量: 153...
The expert panel that authored this review represents a variety of regions, and their guidance reflects clinical and real-world evidence. Selecting Treatment for mCRC in the Third-line Setting The European Society for Medical Oncology (ESMO) and National Comprehensive Cancer Network (NCCN) guidelines...